Low Levels of Her2/neu Expressed by Ewing's Family Tumor Cell Lines Can Redirect Cytokine-Induced Killer Cells
Open Access
- 15 June 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (12), 4561-4570
- https://doi.org/10.1158/1078-0432.ccr-05-0157
Abstract
Purpose: To identify novel treatments for pediatric solid tumors and/or for malignancies with low-level Her2/neu expression.Keywords
This publication has 38 references indexed in Scilit:
- Fas Ligand Is Present in Tumors of the Ewing's Sarcoma Family and Is Cleaved into a Soluble Form by a MetalloproteinaseThe American Journal of Pathology, 1998
- Primary Malignant Epithelial Tumors of the Liver in Children: A Study of DNA Content and Oncogene ExpressionPediatric and Developmental Pathology, 1998
- Bispecific antibodies for treatment of cancer in experimental animal models and manAdvanced Drug Delivery Reviews, 1998
- Prognostic indicators for neuroblastoma: Stage, grade, DNA ploidy, MIB‐1‐proliferation index, p53, HER‐2/neu and EGFr–a survival studyJournal of Surgical Oncology, 1995
- Bispecific HER2 × CD3 Antibodies Enhance T-Cell Cytotoxicity in Vitro and Localize to HER2-Overexpressing Xenografts in Nude MiceClinical Immunology and Immunopathology, 1995
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tractGynecologic Oncology, 1991
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVOThe Lancet, 1986
- Chromosome Translocation in Peripheral NeuroepitheliomaNew England Journal of Medicine, 1984